Nalaganje...
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We characterized tofacitinib pharmacokinetics in patients with moderate to severe UC, and the effects of covariates on variability in pharmacokinetic parameter estimates. Data were pooled from...
Shranjeno v:
| izdano v: | Clin Pharmacol Drug Dev |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7986169/ https://ncbi.nlm.nih.gov/pubmed/33513294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.899 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|